Skip to main content

Program Overview

The Scientific Business Development and Management Program enables 21st century academic researchers to develop the business management and legal skill sets to plan, execute, evaluate, and transition a Transboundary Animal Disease (TAD) Research and Development (R&D) technology to the global marketplace.

This international program targets graduate students, post-doctoral fellows, and early career faculty, including industry and academic scientists interested in understanding the business regulations, federal and international processes, and research requirements for taking basic and/or applied high consequence TAD research through the "valley of death" to technology transition.

  • Develop future Homeland Security professionals who can act with global, applied, and commercial capacity to transition new TAD Department of Homeland Security (DHS) R&D technologies for stakeholder use
  • Understand how technology transition occurs to validate the biological product and/or concepts through the research development testing and evaluation cycle
  • Develop and complete a business plan to take a biological product and/or concept to the global marketplace

 

The program consists of the following components that target commercialization for biological countermeasures (i.e., vaccines, diagnostics, therapeutics, and biologically relevant specimens):

  • Targeted R&D technology transition online course modules
    • Bench: Developing a Strategic Plan of Work
    • Technology Transition: Biological Product and Component Validation
    • Business: Transition of a TAD R&D Product
  • Scenario-based follow on projects
  • Program evaluation

 

Sponsored by the Department of Homeland Security Science & Technology Directorate (S&T), this program trains a cadre of groups to increase the resiliency for DHS S&T's R&D global effectiveness of the entire Homeland Security Enterprise (HSE) to develop biological countermeasures using partnerships and facilities globally.